Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease
Editat de Sorin Breneren Limba Engleză Paperback – 11 ian 2021
A clinically relevant and updated compendium of data pertaining to this field is also presented, as well as the anticipated trends and innovations likely to occur in the next 3-5 years.
- Summarizes a large body of evidence into concrete, relevant recommendations that is readily adapted by practicing clinicians
- Explores the current status of DAPT, controversial topics, and future developments and trends in this field
- Edited and contributed by renowned cardiologists in the field
Preț: 557.14 lei
Preț vechi: 733.26 lei
-24% Nou
Puncte Express: 836
Preț estimativ în valută:
106.63€ • 112.49$ • 88.86£
106.63€ • 112.49$ • 88.86£
Carte tipărită la comandă
Livrare economică 27 decembrie 24 - 10 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128205365
ISBN-10: 0128205369
Pagini: 220
Ilustrații: Approx. 180 illustrations (180 in full color)
Dimensiuni: 191 x 235 x 18 mm
Greutate: 0.41 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128205369
Pagini: 220
Ilustrații: Approx. 180 illustrations (180 in full color)
Dimensiuni: 191 x 235 x 18 mm
Greutate: 0.41 kg
Editura: ELSEVIER SCIENCE
Public țintă
Practitioners in Internal Medicine, Cardiology, Neurology, Vascular Medicine and Cardiovascular Surgery, Fellows in trainingCuprins
- Platelets and arterial disease – initiation, progression and destabilization of atherosclerotic vascular disease
- Platelet physiology and pharmacology – relevant considerations for patient care
- The development of dual antiplatelet therapy – physiologic and clinical implications of multiple pathway inhibition of platelet function
- Acute coronary syndromes and percutaneous coronary intervention – current recommendations for dual antiplatelet therapy. Are guidelines reflecting the data?
- Peripheral arterial disease – a different kind of arterial disease? The role of antiplatelet therapy in prevention and treatment of limb ischemia
- Cerebrovascular disease – what is the role of DAPT for prevention and treatment of ischemic stroke?
- Competing risks in DAPT duration of therapy – the case for shorter treatment
- DAPT may prevent coronary ischemic events beyond one year – the case for extended DAPT treatment
- How to integrate risk of bleeding and ischemic events in clinical medicine? The role of risk scores
- Moving from DAPT to monotherapy based on P2Y12 receptor blockade – why it could be a novel paradigm?
- The conundrum of simultaneous antiplatelet and antithrombotic therapy – how to resolve it?
- A look to the future